VIOL Co (XKRX:335890) Change In Receivables : ₩0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is VIOL Co Change In Receivables?

VIOL Co's change in receivables for the quarter that ended in Mar. 2025 was ₩0 Mil. It means VIOL Co's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

VIOL Co's change in receivables for the fiscal year that ended in Dec. 2024 was ₩-2,358 Mil. It means VIOL Co's Accounts Receivable increased by ₩2,358 Mil from Dec. 2023 to Dec. 2024 .

VIOL Co's Accounts Receivable for the quarter that ended in Mar. 2025 was ₩10,154 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. VIOL Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 55.55.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. VIOL Co's liquidation value for the three months ended in Mar. 2025 was ₩83,009 Mil.

VIOL Co Change In Receivables Historical Data

The historical data trend for VIOL Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VIOL Co Change In Receivables Chart

VIOL Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-2,041.68

1,247.92

-1,310.74

-485.31

-2,358.21

VIOL Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

VIOL Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩0 Mil.

VIOL Co (XKRX:335890) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

VIOL Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	10153.873	/	16680.272	*	91
=	55.55

2. In Ben Graham's calculation of liquidation value, VIOL Co's accounts receivable are only considered to be worth 75% of book value:

VIOL Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	80797.236	-	8949.15	+	0.75 * 10153.873	+	0.5 * 7091.526
=	83,009

VIOL Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of VIOL Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

VIOL Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » VIOL Co Ltd (XKRX:335890) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

744 Pangyo-ro, Bundagu-gu, C-808, 809 Bundang Technopark C, Gyeonggi-do, Seoul, KOR, 13510

Website

http://www.viol.co.kr

VIOL Co Ltd is engaged in manufacturing and marketing of medical devices for skincare treatment and recovery. The product portfolio includes SkinStamp, SYLFIRM, SCARLET, O Media - RS, O Media - RI, and O Media - Hmgf H.

VIOL Co Headlines

No Headlines